HEADER TRANSFERASE 11-AUG-06 2I0Y TITLE CFMS TYROSINE KINASE (FGF KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CFMS TYROSINE KINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 EC: 2.7.10.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS TYROSINE KINASE, KINASE INHIBITOR COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.SCHUBERT,C.SCHALK-HIHI REVDAT 7 21-FEB-24 2I0Y 1 REMARK SEQADV REVDAT 6 23-AUG-17 2I0Y 1 SOURCE REVDAT 5 24-FEB-09 2I0Y 1 VERSN REVDAT 4 09-OCT-07 2I0Y 1 REMARK REVDAT 3 06-MAR-07 2I0Y 1 JRNL REVDAT 2 16-JAN-07 2I0Y 1 JRNL REVDAT 1 28-NOV-06 2I0Y 0 JRNL AUTH C.SCHUBERT,C.SCHALK-HIHI,G.T.STRUBLE,H.C.MA,I.P.PETROUNIA, JRNL AUTH 2 B.BRANDT,I.C.DECKMAN,R.J.PATCH,M.R.PLAYER,J.C.SPURLINO, JRNL AUTH 3 B.A.SPRINGER JRNL TITL CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF JRNL TITL 2 COLONY-STIMULATING FACTOR-1 RECEPTOR (CFMS) IN COMPLEX WITH JRNL TITL 3 TWO INHIBITORS. JRNL REF J.BIOL.CHEM. V. 282 4094 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17132624 JRNL DOI 10.1074/JBC.M608183200 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 27350 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.246 REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.600 REMARK 3 FREE R VALUE TEST SET COUNT : 2066 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 27958 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.97 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2578 REMARK 3 BIN R VALUE (WORKING SET) : 0.3100 REMARK 3 BIN FREE R VALUE : 0.3270 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 214 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.022 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2286 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 101 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.53000 REMARK 3 B22 (A**2) : -3.53000 REMARK 3 B33 (A**2) : 7.05000 REMARK 3 B12 (A**2) : 0.84000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.17 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.22 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ANISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : CNX BULK SOLVENT MODEL USED REMARK 3 KSOL : 0.42 REMARK 3 BSOL : 57.42 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP_OLD.PARAM REMARK 3 PARAMETER FILE 2 : INH.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN_OLD.TOP REMARK 3 TOPOLOGY FILE 2 : INH.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2I0Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000038999. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUL-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99997 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32580 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.790 REMARK 200 RESOLUTION RANGE LOW (A) : 26.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06900 REMARK 200 FOR THE DATA SET : 12.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.61100 REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX 2000 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, SODIUM ACETATE, LI2SO4, PH REMARK 280 5.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.53500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 23.40289 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 48.22333 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 40.53500 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 23.40289 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 48.22333 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 40.53500 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 23.40289 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 48.22333 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 46.80579 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 96.44667 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 46.80579 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 96.44667 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 46.80579 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 96.44667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1081 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 535 REMARK 465 VAL A 536 REMARK 465 ASP A 537 REMARK 465 TYR A 538 REMARK 465 LYS A 539 REMARK 465 TYR A 540 REMARK 465 LYS A 541 REMARK 465 GLN A 542 REMARK 465 LYS A 543 REMARK 465 PRO A 544 REMARK 465 LYS A 545 REMARK 465 TYR A 546 REMARK 465 GLN A 547 REMARK 465 GLY A 558 REMARK 465 ASN A 559 REMARK 465 ASP A 565 REMARK 465 PRO A 566 REMARK 465 THR A 567 REMARK 465 GLN A 568 REMARK 465 LEU A 569 REMARK 465 PRO A 570 REMARK 465 TYR A 571 REMARK 465 ASN A 572 REMARK 465 PRO A 680 REMARK 465 PRO A 681 REMARK 465 GLY A 682 REMARK 465 LEU A 683 REMARK 465 GLU A 684 REMARK 465 TYR A 685 REMARK 465 SER A 686 REMARK 465 TYR A 687 REMARK 465 ASN A 688 REMARK 465 PRO A 689 REMARK 465 SER A 690 REMARK 465 HIS A 691 REMARK 465 ASN A 692 REMARK 465 PRO A 693 REMARK 465 GLU A 694 REMARK 465 GLU A 695 REMARK 465 ASN A 814 REMARK 465 ASP A 917 REMARK 465 ARG A 918 REMARK 465 ARG A 919 REMARK 465 GLU A 920 REMARK 465 ARG A 921 REMARK 465 ASP A 922 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 916 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1086 O HOH A 1093 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 555 135.39 47.30 REMARK 500 TYR A 556 -139.96 -172.86 REMARK 500 LEU A 611 156.72 -33.18 REMARK 500 HIS A 623 -162.21 -124.71 REMARK 500 ARG A 777 -1.27 71.45 REMARK 500 ASP A 778 44.11 -146.55 REMARK 500 THR A 787 -161.28 -113.16 REMARK 500 GLN A 913 -53.93 81.39 REMARK 500 ALA A 914 -42.64 68.51 REMARK 500 GLN A 915 147.46 -178.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5CN A 1000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2I0V RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH A QUINOLONE INHIBITOR REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CLONE WAS TRIMMED TO RESIDUES 538-922 AND REMARK 999 THE KINASE INSERT DOMAIN (RESIDUES 679-752) REMARK 999 WAS REPLACED WITH THE SEQUENCE OF THE KINASE REMARK 999 INSERT DOMAIN FROM THE FGF RECEPTOR. DBREF 2I0Y A 538 678 UNP P07333 CSF1R_HUMAN 538 678 DBREF 2I0Y A 753 922 UNP P07333 CSF1R_HUMAN 753 922 SEQADV 2I0Y GLY A 535 UNP P07333 EXPRESSION TAG SEQADV 2I0Y VAL A 536 UNP P07333 EXPRESSION TAG SEQADV 2I0Y ASP A 537 UNP P07333 EXPRESSION TAG SEQADV 2I0Y ARG A 679 UNP P07333 SEE REMARK 999 SEQADV 2I0Y PRO A 680 UNP P07333 SEE REMARK 999 SEQADV 2I0Y PRO A 681 UNP P07333 SEE REMARK 999 SEQADV 2I0Y GLY A 682 UNP P07333 SEE REMARK 999 SEQADV 2I0Y LEU A 683 UNP P07333 SEE REMARK 999 SEQADV 2I0Y GLU A 684 UNP P07333 SEE REMARK 999 SEQADV 2I0Y TYR A 685 UNP P07333 SEE REMARK 999 SEQADV 2I0Y SER A 686 UNP P07333 SEE REMARK 999 SEQADV 2I0Y TYR A 687 UNP P07333 SEE REMARK 999 SEQADV 2I0Y ASN A 688 UNP P07333 SEE REMARK 999 SEQADV 2I0Y PRO A 689 UNP P07333 SEE REMARK 999 SEQADV 2I0Y SER A 690 UNP P07333 SEE REMARK 999 SEQADV 2I0Y HIS A 691 UNP P07333 SEE REMARK 999 SEQADV 2I0Y ASN A 692 UNP P07333 SEE REMARK 999 SEQADV 2I0Y PRO A 693 UNP P07333 SEE REMARK 999 SEQADV 2I0Y GLU A 694 UNP P07333 SEE REMARK 999 SEQADV 2I0Y GLU A 695 UNP P07333 SEE REMARK 999 SEQADV 2I0Y GLN A 696 UNP P07333 SEE REMARK 999 SEQADV 2I0Y LEU A 697 UNP P07333 SEE REMARK 999 SEQADV 2I0Y SER A 698 UNP P07333 SEE REMARK 999 SEQADV 2I0Y SER A 699 UNP P07333 SEE REMARK 999 SEQRES 1 A 335 GLY VAL ASP TYR LYS TYR LYS GLN LYS PRO LYS TYR GLN SEQRES 2 A 335 VAL ARG TRP LYS ILE ILE GLU SER TYR GLU GLY ASN SER SEQRES 3 A 335 TYR THR PHE ILE ASP PRO THR GLN LEU PRO TYR ASN GLU SEQRES 4 A 335 LYS TRP GLU PHE PRO ARG ASN ASN LEU GLN PHE GLY LYS SEQRES 5 A 335 THR LEU GLY ALA GLY ALA PHE GLY LYS VAL VAL GLU ALA SEQRES 6 A 335 THR ALA PHE GLY LEU GLY LYS GLU ASP ALA VAL LEU LYS SEQRES 7 A 335 VAL ALA VAL LYS MET LEU LYS SER THR ALA HIS ALA ASP SEQRES 8 A 335 GLU LYS GLU ALA LEU MET SER GLU LEU LYS ILE MET SER SEQRES 9 A 335 HIS LEU GLY GLN HIS GLU ASN ILE VAL ASN LEU LEU GLY SEQRES 10 A 335 ALA CYS THR HIS GLY GLY PRO VAL LEU VAL ILE THR GLU SEQRES 11 A 335 TYR CYS CYS TYR GLY ASP LEU LEU ASN PHE LEU ARG ARG SEQRES 12 A 335 LYS ARG PRO PRO GLY LEU GLU TYR SER TYR ASN PRO SER SEQRES 13 A 335 HIS ASN PRO GLU GLU GLN LEU SER SER ARG ASP LEU LEU SEQRES 14 A 335 HIS PHE SER SER GLN VAL ALA GLN GLY MET ALA PHE LEU SEQRES 15 A 335 ALA SER LYS ASN CYS ILE HIS ARG ASP VAL ALA ALA ARG SEQRES 16 A 335 ASN VAL LEU LEU THR ASN GLY HIS VAL ALA LYS ILE GLY SEQRES 17 A 335 ASP PHE GLY LEU ALA ARG ASP ILE MET ASN ASP SER ASN SEQRES 18 A 335 TYR ILE VAL LYS GLY ASN ALA ARG LEU PRO VAL LYS TRP SEQRES 19 A 335 MET ALA PRO GLU SER ILE PHE ASP CYS VAL TYR THR VAL SEQRES 20 A 335 GLN SER ASP VAL TRP SER TYR GLY ILE LEU LEU TRP GLU SEQRES 21 A 335 ILE PHE SER LEU GLY LEU ASN PRO TYR PRO GLY ILE LEU SEQRES 22 A 335 VAL ASN SER LYS PHE TYR LYS LEU VAL LYS ASP GLY TYR SEQRES 23 A 335 GLN MET ALA GLN PRO ALA PHE ALA PRO LYS ASN ILE TYR SEQRES 24 A 335 SER ILE MET GLN ALA CYS TRP ALA LEU GLU PRO THR HIS SEQRES 25 A 335 ARG PRO THR PHE GLN GLN ILE CYS SER PHE LEU GLN GLU SEQRES 26 A 335 GLN ALA GLN GLU ASP ARG ARG GLU ARG ASP HET 5CN A1000 25 HETNAM 5CN 5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4- HETNAM 2 5CN METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE FORMUL 2 5CN C19 H21 N3 O3 FORMUL 3 HOH *101(H2 O) HELIX 1 1 PRO A 578 ASN A 580 5 3 HELIX 2 2 HIS A 623 GLY A 641 1 19 HELIX 3 3 LEU A 671 ARG A 677 1 7 HELIX 4 4 SER A 698 LYS A 772 1 22 HELIX 5 5 ALA A 780 ARG A 782 5 3 HELIX 6 6 ASN A 788 HIS A 790 5 3 HELIX 7 7 PHE A 797 ARG A 801 5 5 HELIX 8 8 PRO A 818 MET A 822 5 5 HELIX 9 9 ALA A 823 ASP A 829 1 7 HELIX 10 10 THR A 833 SER A 850 1 18 HELIX 11 11 ASN A 862 GLY A 872 1 11 HELIX 12 12 PRO A 882 TRP A 893 1 12 HELIX 13 13 GLU A 896 ARG A 900 5 5 HELIX 14 14 THR A 902 GLU A 912 1 11 SHEET 1 A 2 LYS A 551 ILE A 552 0 SHEET 2 A 2 CYS A 774 ILE A 775 -1 O ILE A 775 N LYS A 551 SHEET 1 B 5 LEU A 582 ALA A 590 0 SHEET 2 B 5 GLY A 594 ALA A 601 -1 O GLU A 598 N GLY A 585 SHEET 3 B 5 LYS A 612 LEU A 618 -1 O VAL A 613 N ALA A 599 SHEET 4 B 5 LEU A 660 GLU A 664 -1 O THR A 663 N ALA A 614 SHEET 5 B 5 LEU A 649 CYS A 653 -1 N LEU A 650 O ILE A 662 SHEET 1 C 3 GLY A 669 ASP A 670 0 SHEET 2 C 3 VAL A 784 LEU A 786 -1 O LEU A 786 N GLY A 669 SHEET 3 C 3 ALA A 792 ILE A 794 -1 O LYS A 793 N LEU A 785 SHEET 1 D 2 ILE A 810 VAL A 811 0 SHEET 2 D 2 ARG A 816 LEU A 817 -1 O LEU A 817 N ILE A 810 SITE 1 AC1 14 LEU A 588 ALA A 614 LYS A 616 THR A 663 SITE 2 AC1 14 GLU A 664 TYR A 665 CYS A 666 CYS A 667 SITE 3 AC1 14 GLY A 669 LEU A 785 PHE A 797 ALA A 800 SITE 4 AC1 14 ARG A 801 HOH A1092 CRYST1 81.070 81.070 144.670 90.00 90.00 120.00 H 3 9 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012335 0.007122 0.000000 0.00000 SCALE2 0.000000 0.014243 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006912 0.00000